Evidence map›Paper›PMID 31709321›Full record

ArticleJACC. Basic to translational science2019

A Molecularly Detailed Na

Jonathan D Moreno, Wandi Zhu, Kathryn Mangold, Woenho Chung, Jonathan R Silva

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Late IMedicinal research reviews · 2026
    Review
  2. Article
  3. COMPUTATIONAL ANALYSIS OF THE NOVEL LQT3 MUTATIONS G1481V AND Q1491H IN MYOCARDIAL AND PURKINJE CELLS.Annual Modeling and Simulation Conference (ANNSIM). Annual Modeling and Simulation Conference (Online) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Unravelling NovelInternational journal of molecular sciences · 2023
    Article
  8. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Calibration of ionic and cellular cardiac electrophysiology models.Wiley interdisciplinary reviews. Systems biology and medicine · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonathan D MorenoDivision of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.
Wandi ZhuDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Kathryn MangoldDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Woenho ChungDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Jonathan R SilvaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Washington University in St. Louis · US

Funding

PRINCIPLES IN CARDIVASCULAR RESEARCH TRAINING PROGRAMT32HL007081 · NHLBI · WASHINGTON UNIVERSITY · PI Abhinav Diwan, Karen Ellen Joynt Maddox · 1985 to 2026
$10.6M
MODULATION OF CARDIAC NAV CHANNEL FUNCTION AND ELECTROPHYSIOLOGY BY INTERACTING MOLECULESR01HL136553 · NHLBI · WASHINGTON UNIVERSITY · PI SILVA, JONATHAN R · 2017 to 2021
$1.9M
NHLBI NIH HHS R01 HL136553NHLBI NIH HHS T32 HL007081
6 · The paper itself

Abstract

Antiarrhythmic treatment strategies remain suboptimal due to our inability to predict how drug interactions with ion channels will affect the ability of the tissues to initiate and sustain an arrhythmia. We built a multiscale molecular model of the Na

Indexed as

APD, action potential durationarrhythmiasBCL2000, basic cycle length of 2,000 mscomputational biologyDIII-VSD, domain III voltage-sensing domainEAD, early afterdepolarizationIC50, half-maximal inhibitory voltageion channelsLQT3, long QT syndrome type 3pharmacologyRFI, recovery from inactivationSSA, steady-state availabilitytranslational studiesUDB, use-dependent blockV1/2, half-maximal voltageVSD, voltage-sensing domain

Identifiers

PMID31709321
PMCPMC6834944
OpenAlexW2982305165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.